FDA Approves Xeomin for temporary improvement to frown lines between the brows
Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
July 27, 2011 · by Medesthetic Center · in What's New · Tags: frown lines beaumont, skin treatments beaumont, wrinkles beaumont, Xeomin, Xeomin beaumont, xeomin setx, Xeomin southeast texas, xeomin treatments beaumont